Bayar, E. Et Al. 2021. DNA Damage in AML-12 Hepatocytes and 3T3-L1 Adipocytes Treated with Clopidogrel. CURRENT DRUG SAFETY , vol.16, no.3 , 252-258.

Bayar, E., Cevik, M., Caker, S., Cagatay, P., & SÜSLEYİCİ, B., (2021). DNA Damage in AML-12 Hepatocytes and 3T3-L1 Adipocytes Treated with Clopidogrel. CURRENT DRUG SAFETY , vol.16, no.3, 252-258.

Bayar, Elif Et Al. "DNA Damage in AML-12 Hepatocytes and 3T3-L1 Adipocytes Treated with Clopidogrel," CURRENT DRUG SAFETY , vol.16, no.3, 252-258, 2021

Bayar, Elif Et Al. "DNA Damage in AML-12 Hepatocytes and 3T3-L1 Adipocytes Treated with Clopidogrel." CURRENT DRUG SAFETY , vol.16, no.3, pp.252-258, 2021

Bayar, E. Et Al. (2021) . "DNA Damage in AML-12 Hepatocytes and 3T3-L1 Adipocytes Treated with Clopidogrel." CURRENT DRUG SAFETY , vol.16, no.3, pp.252-258.

@article{article, author={Elif Bayar Et Al. }, title={DNA Damage in AML-12 Hepatocytes and 3T3-L1 Adipocytes Treated with Clopidogrel}, journal={CURRENT DRUG SAFETY}, year=2021, pages={252-258} }